J&J units launch prostate cancer drug suit
31-05-2022
Fed Circuit revives bid to invalidate robotic surgery patent
03-05-2022
J&J secures injunction against medical device counterfeiter
07-12-2021
Michael Vi / Shutterstock.com
The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board (PTAB) rulings that a Johnson & Johnson (J&J) subsidiary’s patent is valid and infringed.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit, Patent Trial and Appeal Board, Ethicon, Johnson & Johnson
